Drug Description in Trials / DrugBank / KEGG DRUG

  

Search results

No. 薬物名（臨床試験情報から抽出） DrugBank KEGG DRUG KEGG GENES KEGG PATHWAY 指定難病告示番号
11.0 MIU IL-2 per day1件: Human interleukin-2 (IL-2)---1件: 2 💬
22.0 MIU IL-2 per day1件: Human interleukin-2 (IL-2)---1件: 2 💬
3Anti-IL-201件: Fletikumab (Anti-IL-20)1件: Fletikumab 💬 1件: IL20 💬 3件: Cytokine-cytokine receptor interaction, JAK-STAT signaling pathway, Viral protein interaction with cytokine and cytokine receptor 💬1件: 46 💬
4Anti-IL-20 (109-0012)1件: Fletikumab (Anti-IL-20)1件: Fletikumab 💬 1件: IL20 💬 3件: Cytokine-cytokine receptor interaction, JAK-STAT signaling pathway, Viral protein interaction with cytokine and cytokine receptor 💬1件: 46 💬
5Anti-IL-23 monoclonal antibody----1件: 96 💬
6Anticorpo monoclonale anti IL-23----1件: 96 💬
7Anticorpo monoclonale anti-IL-23----1件: 96 💬
8IL-21件: Human interleukin-2 (IL-2)---5件: 2, 46, 49, 53, 56 💬
9IL-22Fc1件: Efmarodocokin alfa (IL-22Fc)1件: Efmarodocokin alfa 💬 1件: IL22 💬 4件: Cytokine-cytokine receptor interaction, Inflammatory bowel disease, JAK-STAT signaling pathway, Th17 cell differentiation 💬2件: 96, 97 💬
10Low-dose IL-21件: Human interleukin-2 (IL-2)---1件: 56 💬
11Recombinant human anti IL-22 monoclonal antibody IgG1----1件: 46 💬
12TYF-IL-2Rg gene-modified autologous stem cells----1件: 65 💬
13UTTR1147A, IL22-Fc, IL-22Fc1件: Efmarodocokin alfa (IL-22Fc)1件: Efmarodocokin alfa 💬 1件: IL22 💬 4件: Cytokine-cytokine receptor interaction, Inflammatory bowel disease, JAK-STAT signaling pathway, Th17 cell differentiation 💬2件: 96, 97 💬